| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11013802 | Clinical Oncology | 2018 | 8 Pages |
Abstract
MRIgRT is widely applicable within the field of radiation oncology and new clinical uses continue to emerge. At our institution to date, applications such as ART for gastrointestinal cancers and accelerated partial breast irradiation (APBI) for breast cancer have become dominant indications, although this is likely to continue to evolve.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
L.E. Henke, J.A. Contreras, O.L. Green, B. Cai, H. Kim, M.C. Roach, J.R. Olsen, B. Fischer-Valuck, D.F. Mullen, R. Kashani, M.A. Thomas, J. Huang, I. Zoberi, D. Yang, V. Rodriguez, J.D. Bradley, C.G. Robinson, P. Parikh, J. Michalski,